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During angiogenesis, nascent vascular sprouts fuse
to form vascular networks, enabling efficient circula-
tion. Mechanisms that stabilize the vascular plexus
are not well understood. Sphingosine 1-phosphate
(S1P) is a blood-borne lipid mediator implicated in
the regulation of vascular and immune systems.
Here we describe a mechanism by which the G
protein-coupled S1P receptor-1 (S1P1) stabilizes
the primary vascular network. A gradient of S1P1
expression from the mature regions of the vascular
network to the growing vascular front was observed.
In the absence of endothelial S1P1, adherens junc-
tions are destabilized, barrier function is breached,
and flow is perturbed, resulting in abnormal vascular
hypersprouting. Interestingly, S1P1 responds to
S1P as well as laminar shear stress to transduce
flow-mediated signaling in endothelial cells both
in vitro and in vivo. These data demonstrate that
blood flow and circulating S1P activate endothelial
S1P1 to stabilize blood vessels in development and
homeostasis.
INTRODUCTION
Angiogenesis, the formation of new blood vessels from pre-
existing vasculature, is a fundamental event in embryonic
development, physiological processes, organ regeneration,
and diseases (Carmeliet and Jain, 2011). The multifunctional
endothelial cells (ECs) initiate, sustain, and terminate angiogen-
esis under a variety of physiological and pathological conditions
(Butler et al., 2010; Gaengel et al., 2009).
Paracrine activation of ECs by the vascular endothelial
growth factor (VEGF) is a major initiating event in angiogenesis
(Ferrara, 2009). The primary stimulus for the extravascular
expression of VEGF is hypoxia: reduced oxygen tension sig-
nals via the prolyl hydroxylase enzymes to regulate the
abundance of hypoxia-inducible transcription factors, which600 Developmental Cell 23, 600–610, September 11, 2012 ª2012 Elsdirectly induce VEGF expression (Fraisl et al., 2009). VEGF acti-
vation of its receptors on the endothelium (VEGFR-2 and
VEGFR-3) results in the formation of morphologically distinct
tip cells (Gerhardt and Betsholtz, 2005). It was recently shown
that VEGFR-2 induction of the Notch ligand Dll4 inhibits tip
cell formation by activating the Notch1 receptor in the neigh-
boring cells, thereby suppressing tip cell formation (Hellstro¨m
et al., 2007; Suchting et al., 2007). Concomitantly, stalk cells,
which trail behind tip cells, proliferate and differentiate into
lumen-containing nascent vascular sprouts (Kamei et al.,
2006; Zeeb et al., 2010) and fuse into a primary vascular loop,
which is a key step in the initiation of blood flow (Fantin et al.,
2010).
Although blood flow is important for blood vessel differentia-
tion, cessation of hypersprouting, remodeling, and homeo-
stasis, molecular mechanisms by which ECs sense biomechan-
ical shear forces are poorly understood (Hahn and Schwartz,
2009). In vitro studies have identified a signaling complex con-
taining vascular endothelial (VE)-cadherin; platelet endothelial
cell adhesion molecule (PECAM)-1; and VEGFR-2, which was
required for the transduction of biomechanical forces to cyto-
skeleton realignment and NF-kB activation in ECs (Tzima
et al., 2005). A recent study identified flow-induced miR-126
as a critical factor in aortic arch sprouting angiogenesis in ze-
brafish (Nicoli et al., 2010). Further, using a microfluidic device,
it was proposed that fluid shear forces inhibit EC sprouting
induced by positive VEGF gradients in vitro (Song and Munn,
2011). However, the relationship of flow-mediated biome-
chanical signals with angiogenic factor signaling in vivo is not
clear.
In addition to physiological processes, such as embryonic
development, organ growth, and wound healing, angiogenesis
is critical for various diseases, such as cancer, age-related
macular degeneration (AMD), rheumatoid arthritis, and psori-
asis. Thus, intensive efforts have been made to develop new
antiangiogenic therapeutics. Indeed, an antibody against
VEGF was approved for therapy in metastatic cancers and in
AMD (Carmeliet and Jain, 2011; Ferrara, 2009). Better under-
standing of major mechanisms of angiogenesis may eventually
lead to the development of more effective antiangiogenic
therapies.evier Inc.
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Figure 1. Endothelial S1P1 Regulates
Retinal Vascular Development
(A–D) Retinas from postnatal day 4 (P4) S1p1 KO
animals (WT [n = 6] and S1p1 KO [n = 7]) were
stained in lectin to visualize retinal vasculature.
(E–H) Vascularization (E), tip cell numbers (F),
branch points (G), and vessel diameter (H) were
quantitated as described in Experimental Proce-
dures.
(I–L) EC-specific loss of S1P1 (S1p1 ECKO)
resulted in retinal hypersprouting.
(M–P) Reduced vascularization (M), increased tip
cell numbers (N), reduced branch points (O), and
increased vessel diameter (P) were also observed
in S1p1 ECKO animals (WT [n = 3] and S1p1
ECKO [n = 6]).
See also Figures S1 and S2. All values are
mean ± SEM.
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S1P1 Senses Flow and Sustains AngiogenesisSphingosine 1-phosphate (S1P), a bioactive lysophospholipid,
is highly enriched in plasma by binding to ApoM in the HDL
particle (Christoffersen et al., 2011). Its prototypic receptor
S1P1 is induced in angiogenic ECs (Hla et al., 2001; Lee et al.,
1998) and is essential for vascular development (Liu et al.,
2000). S1P affects various aspects of vascular function, such
as vascular permeability (Sanchez et al., 2003), cell migration
(Paik et al., 2001), cell-cell adhesion (Lee et al., 1999), survival
(Lee et al., 1998), and tumor angiogenesis (Chae et al., 2004).
However, the role of S1P in physiological angiogenesis has
not been characterized in the postnatal period. Importantly, the
relationship of S1P signaling with primary angiogenic factors,
such as VEGF and Notch, and its role in biomechanical signaling
are completely unknown.
Here we developed inducible genetic loss-of-function (LOF)
and gain-of-function (GOF) models to investigate the role of
S1P1 in postnatal angiogenesis. We demonstrate that S1P1 is
essential for stabilization of a flow-competent neovessel
network, and in its absence, breach of vascular barrier function,
tissue hypoxia, and abnormal vascular patterning ensue. The
requirement for S1P1 in vascular network stability is important
for normal vascular development and homeostasis. Notably,
S1P1 not only responds to the lysophospholipid S1P, but also
is critical for EC mechanotransduction. These findings provide
a mechanistic basis for intravascular, flow-dependent vascular
stabilization of the primary vascular network.Developmental Cell 23, 600–610, SeRESULTS
Genetic Ablation of Murine S1pr1
Results in Abnormal Retinal
Vasculature
We developed a global and inducible
gene deletion model for S1pr1 in
the mouse (S1pr1f/f Rosa26-Cre-ERT2;
referred to as S1p1 KO). When S1p1 KO
mice were given tamoxifen from post-
natal day 1 (P1) to P3, efficient and
specific gene deletion was observed in
the retina at P4 and thereafter (Figures
S1A and S1B available online). Analysisof the retina indicated a profound alteration in vascular pheno-
type in S1p1 KOmice. Expansion of the primary vascular plexus
was severely affected, resulting in abnormal vascular patterning
(Figures 1A and 1B). Specifically, an increased number of filopo-
dia-containing tip cells, branch points, and dilated vessels were
observed (Figures 1C–1H).
To determine whether cell proliferation is responsible, we
performed a bromodeoxyuridine (BrdU) incorporation assay
using S1p1 KO animals and their littermate controls. Staining
for BrdU followed by lectin was carried out to visualize prolifer-
ating retinal ECs (Figures S1C–S1F). Although there is no
apparent difference in total BrdU+ cell numbers, EC proliferation
(BrdU+Lectin+) in S1p1 KO mouse retinas was increased. Thus,
reduced vascularization in the S1p1 KO mouse retinas was not
caused by a deficiency in EC proliferation.
S1pr1-deleted mice die at embryonic day 10.5–12.5, which
is associated with defective vascular maturation, extensive
hemorrhage, and edema (Allende et al., 2003; Liu et al., 2000).
Further mechanistic studies also indicated the role of S1P1 in
the regulation of EC/pericyte interactions (Paik et al., 2004).
Thus, we examined whether mural cell recruitment was altered
during different stages of the retinal vasculature development.
Interestingly, smooth muscle actin (SMA)+ vascular smooth
muscle cells in arterioles (Figure S1G) or NG2+ pericytes in
capillaries (Figure S1H) were indistinguishable between wild-
type (WT) and S1p1 KO retinal vessels. These results suggestptember 11, 2012 ª2012 Elsevier Inc. 601
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Figure 2. S1P1 Overexpression—S1p1 GOF—Suppresses Sprouting Angiogenesis
(A–F) Retinal vascular plexus formation in S1p1 GOF (P5) mice. S1P1 immunostaining is shown in (B) and (D). Note that the vessel density and the number of tip
cells were markedly reduced upon S1P1 overexpression. (E and F) High power images of the growing vessels at the tip.
(G–I) Quantification results from S1p1 GOF mouse retinas displayed reduced sprouting of tip cells (G), reduced branch points (H), and increased dilation of the
vessels (I) (WT [n = 4] and S1p1 GOF [n = 5]).
See also Figure S1. All values are mean ± SEM.
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S1P1 Senses Flow and Sustains Angiogenesisthat the vascular endothelial alterations observed in the S1p1
KO mice was a primary effect and not secondary to a defect
in mural cell recruitment.
EC-Intrinsic S1P1 Signaling Regulates Vascular
Patterning
We next investigated whether EC-intrinsic S1P1 regulates
vascular development in the retina. We developed EC-specific
inducible knockout mice (S1pr1f/f VE-cadherin-Cre-ERT2;
referred to as S1p1 ECKO) to address this question. Quantitative
RT-PCR analysis using ECs isolated from the lung tissue in WT
and S1p1 ECKO animals shows efficient S1pr1 gene deletion.
Compensatory changes in the expression of S1P2 and S1P3
receptors were not observed (data not shown). Similarly, S1p1
ECKO animals exhibited abnormal vascular phenotype charac-
terized by defective vascularization, hypersprouting, increased
branching, and dilated morphology (Figures 1I–1P). These
results strongly suggest EC-autonomous function of S1P1 in
the regulation of retinal vascular development. We also
examined mural cell recruitment in S1p1 ECKO at different
developmental stages as well as different regions of the retinal
vasculature. Mural cell coverage of the retinal vessels in S1p1
ECKO animals was comparable to WT counterparts (Figures
S1G and S1H).
The vascular phenotype of S1P1 LOF is similar to the attenu-
ated Notch signaling observed in the Dll4+/ mutant retinas
(Hellstro¨m et al., 2007; Suchting et al., 2007), raising the possi-
bility that S1P1 and Notch signaling pathways are epistatic in
the regulation of angiogenesis. However, Notch target genes
were not altered significantly in the retinal tissue of inducible
S1p1 KO mice (Figure S2A). Treatment of human umbilical vein
endothelial cells (HUVEC) with S1P to activate the S1P1 receptor
also did not change the expression of Notch target genes
(data not shown). These data suggest that Notch is not a
downstream target of S1P1 in ECs. Additionally, treatment of602 Developmental Cell 23, 600–610, September 11, 2012 ª2012 ElsHUVEC with Dll4 polypeptide coated on a solid surface
promoted strong induction of Hes1 messenger RNA (mRNA)
expression, while no alteration on S1P1 mRNA expression was
observed (Figure S2B), indicating that S1P1 is not downstream
of Dll4/Notch pathway. Together, these experiments suggest
that the S1P1 signaling pathway is likely parallel to Notch
signaling in neovessel formation.
Overexpression of S1P1 Suppresses Endothelial
Sprouting
Given these findings, we hypothesized that overexpression of
S1P1 might suppress tip cell formation and hypersprouting
in retinal vasculature. To address this, we examined the induc-
ible overexpression of S1P1 in a transgenic mouse system
(S1pr1f/stop/f Rosa26-Cre-ERT2; referred to as S1p1 GOF) (Fig-
ure S1I). Cre-mediated selective S1P1 gene activation was
confirmed by PCR, as shown in Figure S1J. Remarkably, overex-
pression of S1P1 induced a sparse vascular network at mid-
region and fewer tip cells at the vascular leading front (Figures
2A–2F). Quantitative morphometry confirmed reduced tip cells
(Figure 2G), reduced branch points (Figure 2H), and dilated
vasculature (Figure 2I) in S1p1 GOF retinas. Further, mural cell
coverage by SMA+ cells as well as NG2+ cells in S1p1 GOF
were similar toWT counterparts, shown in Figures S1G and S1H.
Gradient of S1P1 Expression in the Retinal Vasculature
We next examined the expression pattern of S1P1 in retinal
vasculature using the S1pr1LacZ/+ mouse (Liu et al., 2000).
S1pr1 expression was increased from the leading front (low) to
the mature, flow-positive regions (high) of the vascular network
(Figures 3A and 3B). X-gal staining was colocalized with an EC
marker, PECAM-1, or lectin (Figures 3C–3G). In contrast, glial
fibrillary acidic protein (GFAP)- (astrocyte marker) and NG2-
(pan-pericyte marker) positive cells were devoid of X-gal stain-
ing (Figures 3H and 3I), indicating the restricted expression ofevier Inc.
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Figure 3. Gradient of S1P1 Expression in the Developing Retinal Vasculature
The expression of the S1pr1 locus in the retinal vasculature was examined by X-gal staining using P4 S1pr1LacZ/+ mice (shown in blue) (A and B), in combination
with PECAM-1 (C and D), lectin (E–G), GFAP (H), or NG2 (I) costaining. Note that high LacZ activity was detected inmature vascular ECs compared to the vascular
leading front and that LacZ expression is restricted to endothelium. Red and white arrowheads indicate tip cells (C, E, and F), and black arrowheads denote
NG2+ cells (I).
See also Figure S3.
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S1P1 Senses Flow and Sustains AngiogenesisS1pr1 in endothelium. Moreover, the graded expression pattern
of S1pr1 was correlated with receptor protein expression,
as determined by immunofluorescence confocal microscopy
(Figure S3).
Dysregulated Blood Flow and Leakage
in S1P1 Null Vessels In Vivo
S1P activation of its receptors in ECs, particularly S1P1 and
S1P3, results in activation of Rac and Rho guanine nucleotide
triphosphatases (GTPases) and coordinated cytoskeletal
changes, which are obligated steps in the assembly of VE-
cadherin-mediated adherens junctions (Lee et al., 1999). Since
proper assembly of the adherens junctions and subsequent
signal transduction events are essential for maintenance of
the EC morphogenesis and functionality (Montero-Balaguer
et al., 2009), S1p1 ECKO mice were analyzed for blood flow
and permeability by intracardiac injection of high molecular
weight fluorescein isothiocyanate (FITC)-dextran (to indicate
vascular leakage) and isolectin B4 (to indicate vascular perfu-
sion). Strikingly, the vessels of the S1p1 ECKO retina displayed
poor isolectin B4 labeling compared to the WT counterparts
(Figures 4A, 4D, 4G, and 4J), suggesting that S1P1 is critical
for proper perfusion of blood vessels. Further, S1p1 ECKO
retinas showed extravascular FITC-dextran, indicating en-
hanced vascular leakage (Figures 4B, 4E, 4H, and 4K). These
results suggest suboptimal blood flow and breach of barrier
function of the vessels in the absence of S1P1.
To further confirm the perturbation in blood flow upon
S1P1 loss, we examined oxygenation of the retinal tissue inDevelopmenS1p1 ECKO mice with oxygen-sensitive compound hypoxyp-
robe-1 (Chen et al., 2009). As shown in Figures 4M–4R,
vascularized areas of the S1p1 ECKO retina were severely
hypoxic compared to the WT counterparts. Moreover, VEGF-
A polypeptide expression was significantly elevated in the
S1p1 ECKO retinas, but not in plasma (Figures S4A and
S4B). These results suggest that loss of S1P1 results in reduced
blood flow, which induces local tissue hypoxia and VEGF-A
expression.
Increased VEGF-A expression in the retina could drive the
hypersprouting phenotype observed in the S1p1 ECKO retinal
vessels. To test this hypothesis, a specific VEGFR-2 inhibitor
SU5416 was administered in combination with FTY720, a potent
functional antagonist which induces proteosomal degradation
of the S1P1 receptor (Oo et al., 2011). Systemic administration
of FTY720 (5 mg/Kg) to newborn mice resulted in increased tip
cell numbers, similar to genetic S1pr1 LOF. Further, FTY720-
induced tip cell formation was significantly suppressed by
SU5416 treatment (Figures S4C–S4E).
Increased phosphorylation of VE-cadherin, especially at Y658
and Y731 residues, is known to be associated with junctional
destabilization and VEGF signaling (Dejana et al., 2008). We
therefore examined the role of S1P1 on the phosphorylation state
of VE-cadherin in vivo. Lung tissue extracts from S1p1 ECKO
animals exhibited 2-fold increase in phospho-VE-cadherin
levels at both Y658 and Y731 (Figure 4S), indicating junctional
destabilization. We also examined the proteolytic sensitivity of
VE-cadherin by trypsin in retina (Gavard and Gutkind, 2006).
The rationale of this experiment is that junction-associatedtal Cell 23, 600–610, September 11, 2012 ª2012 Elsevier Inc. 603
Figure 4. S1P1 Is Critical for Stabilization of the Flow-Competent Vessels
(A–L) Retinas fromWT and S1p1 ECKOmice were imaged after intracardiac injection of FITC-dextran (Mr 2,000 kDa) and lectin. High power images of the WT
(Box1, G–I) and S1p1 ECKO (Box2, J–L) retinas. Arrowheads indicate sites of vascular leakage.
(M–R) Retinal hypoxia was visualized by Hypoxyprobe-1 staining as described in Experimental Procedures.
(S) Total lung lysates fromWT and S1p1 ECKO animals were analyzed for Y658-, and Y731-VE-cadherin levels by immunoblots (WT [n = 5] and S1p1 ECKO [n = 5]).
(T) Retina explants were treated with 0.05% trypsin for 60min, and total protein extracts were analyzed for ECmarkers. Note that VE-cadherin is more sensitive to
trypsin in S1p1 ECKO retinas (WT [n = 3] and S1p1 ECKO [n = 6]).
See also Figure S4. All values are mean ± SEM.
Developmental Cell
S1P1 Senses Flow and Sustains AngiogenesisVE-cadherin will be more trypsin resistant. In contrast, when ad-
herens junctions are destabilized, VE-cadherin will be more
accessible to trypsin cleavage. When retinal tissue was treated
with trypsin ex vivo, S1p1 ECKO showed greater sensitivity
to protease cleavage than the WT counterparts, whereas
other membrane proteins, such as N-cadherin, podocalyxin,
VEGFR-2, and PECAM-1 did not show differential trypsin
sensitivity (Figure 4T), suggesting junctional destabilization in
S1p1 ECKO.
S1P1 Is Essential for Fluid Shear Stress Signaling in ECs
Flow-dependent fluid shear forces activate the endothelial
mechanosensing machinery and trigger intracellular signals,
such as heterotrimeric G protein activation, small GTPase
Rac activation, ERK and Akt phosphorylation, endothelial nitric
oxide synthase (eNOS) activation, and VE-cadherin junction
assembly (Hahn and Schwartz, 2009). Since S1P1 and laminar604 Developmental Cell 23, 600–610, September 11, 2012 ª2012 Elsshear force signals are largely overlapping, we tested if S1P1
receptor itself is required for EC shear stress signaling
in vitro. Antagonism of S1P1 with FTY720-P completely
blocked shear stress-induced adherens junction assembly
(Figures 5A–5D), as well as phosphorylation of ERK, Akt, and
eNOS (Figure 5E) in HUVEC. Similarly, small hairpin RNA
(shRNA)-mediated downregulation of S1P1 also inhibited shear
stress-induced ERK activation (Figure 5F). Further, overexpres-
sion of S1P1 by adenovirus restored shear stress-induced ERK
activation in ECs, in which S1P1 was inhibited by FTY720-P
(Figure 5G). In addition to such acute signaling events, chronic
application of laminar shear stress induces alignment of EC
monolayers to the direction of flow and elongation of cell shape
(Noria et al., 1999) as well as planar polarity of intracellular
organelles, such as the microtubule organizing center and the
Golgi apparatus (Tzima et al., 2003). When S1P1 was downre-
gulated by either shRNA or FTY720-P treatment, shear-inducedevier Inc.
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Figure 5. S1P1 Is Required for Shear Stress-Induced Signaling in EC In Vitro
(A–D) HUVEC were pretreated with FTY720-P, and laminar shear (8 dynes/cm2) was applied for 1 hr. Adherens junction formation was visualized by VE-cadherin
immunofluorescence staining. Arrowheads indicate intercellular gaps.
(E–G) ERK, Akt, and eNOS activation were examined 10 min after laminar shear application in the presence or the absence of FTY720-P (E), shRNA for S1P1
(F), and FTY720-P with adenoviral overexpression of S1P1 (G).
(H) Short-term laminar shear was applied to WT, S5A, or R120A mutants, and immunoblots for ERK activation were carried out.
(I–N) shRNA for S1P1-treated cells, FTY720-P-treated WT, or R120A mutant cells underwent long-term laminar shear (12 hr), and EC alignment was examined.
(O) Percentage of the aligned cell numbers over the total cell numbers were quantified as described in Experimental Procedures.
See also Figure S5. All values are mean ± SD.
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S1P1 Senses Flow and Sustains AngiogenesisEC alignment was significantly suppressed (Figures 5I–5L).
Polarized localization of eNOS in the perinuclear/Golgi region
(Sessa et al., 1995) in the direction of flow was abolished by
FTY720-P treatment (Figure S5A). Remarkably, re-expression
of S1P1 restored EC alignment to the direction of flow (Figures
5M and 5O). These data suggest that S1P1 is necessary for
both acute and chronic signaling events induced by laminar
shear stress in ECs.
The requirement for S1P1 in laminar shear stress signaling
may simply reflect the secretion of S1P (Venkataraman et al.,
2008) followed by export and activation of S1P1. However,
neither pharmacologic inhibition of sphingosine kinases nor
shRNA-mediated knockdown of endothelial S1P transporter
Spns2 (Kawahara et al., 2009) had an effect on laminar shear
stress-induced ERK phosphorylation (Figures S5B–S5D),
raising the possibility that S1P1 can be activated in a ligand-
independent manner in response to laminar shear stress. To
address this hypothesis, we utilized a S1P1 mutant (R120A),
which is deficient in S1P binding (Wang et al., 2001). ThisDevelopmenresidue docks the phosphate moiety of the S1P and thus is
essential for ligand activation of the receptor (Wang et al.,
2001; Hanson et al., 2012). We also used the C-terminal phos-
phorylation-deficient mutant (S1P1S5A), which is defective in
agonist-activated endocytosis and therefore exhibits increased
plasma membrane residency (Oo et al., 2007). As expected, the
S1P1R120A mutant did not respond to S1P or FTY720-P in
ERK activation or internalization experiments (Figures S5E
and S5F). The S1P1S5A mutant still responded to S1P in the
ERK phosphorylation assay, but exhibited defective endocy-
tosis, even after FTY720-P treatment (Figure S5F). In HUVEC,
both S1P1R120A and S1P1S5A mutants restored shear
stress-induced ERK activation when S1P1 was antagonized
by FTY720-P (Figure 5H). Interestingly, the S1P1R120A mutant
allowed laminar shear stress-mediated EC alignment (Figures
5N, 5O, and S5A) and polarized alignment of the Golgi appa-
ratus (eNOS) (Figure S5A), suggesting that the S1P1 receptor
itself, in a ligand-independent manner, plays an essential role
in EC shear stress signaling.tal Cell 23, 600–610, September 11, 2012 ª2012 Elsevier Inc. 605
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Figure 6. In Vivo Requirement for S1P1 in Shear Stress Signaling
(A–D) Expression of S1P1 and VE-cadherin in areas of laminar (descending) and turbulent shear (lesser curvature) in the aorta. Sections of the aorta were
dissected and stained for S1P1 and VE-cadherin (A and B) or EEA-1 (C and D) in en face preparations.
(E–J) Sections of the aorta were stained for total-eNOS (E and F) and phospho-eNOS (G and H). Quantification of phospho- (I) and total eNOS (J) levels in WT
and S1p1 ECKO descending aortas is shown (WT [n = 4] and S1p1 ECKO [n = 4]).
(K and L) Retinal tissues from WT and S1p1 ECKO (P5) were analyzed for phospho-eNOS and total eNOS levels by immunoblots (WT [n = 5] and S1p1 ECKO
[n = 4]).
(M and N) Quantification of the morphological changes observed in the descending aortic region from WT and S1p1 ECKO mice is shown (WT [n = 4] and
S1p1 ECKO [n = 4]).
All values are mean ± SEM.
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Homeostasis
To examine the relationship between S1P1 and flow-dependent
EC function in vivo, we analyzed the linear part of the aorta
(descending aorta), which is subject to steady laminar shear
stress (Davies, 2009). S1P1 expression was observed on the
plasma membrane colocalized with VE-cadherin. In contrast, in
areas of turbulent shear, i.e., the lesser curvature of the aorta,
S1P1 presence at the adherens junctions is lost and S1P1 is
found intracellularly in the endocytotic vesicles, as indicated
by strong colocalization with early endosome antigen (EEA)-1
(Figures 6A–6D).
In S1p1 ECKO, significantly reduced phospho-eNOS staining
was observed in the descending aorta (Figures 6E–6J), suggest-
ing that S1P1 mediates eNOS activation in vivo. In agreement606 Developmental Cell 23, 600–610, September 11, 2012 ª2012 Elswith the results from the aortic vasculature, phosphorylation of
eNOS was significantly reduced in S1p1 ECKO retinas, shown
in Figures 6K and 6L. Interestingly, cellular and nuclear
morphology in the descending aorta from S1p1 ECKO mice
showed significant alterations. Specifically, ECs (both cytoplasm
and nucleus) from S1p1 ECKO mice were round and less
aligned/elongated (Figures 6M and 6N). These data provide
strong in vivo evidence that S1P1 is an essential component of
flow-dependent biomechanical signaling in the endothelium.
DISCUSSION
The main finding of this work is that S1P1 signaling in ECs
regulates sprouting angiogenesis. Lack of S1P1 promoted
hypersprouting, whereas overexpression of S1P1 suppressedevier Inc.
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Since tip/stalk cell specification is a key event in subsequent
vascular patterning events, i.e., hierarchical branching and
vascular network architecture, the entire vascular network
morphology is critically dependent on precise signaling of S1P1.
Interestingly, S1P1 expression is strongly induced in the
mature, flow-positive regions of the vascular network. In sharp
contrast, the sprouting vascular front, the tip, and stalk cell
region expressed very low levels of S1pr1. The induction of
S1P1 could be due to the action of flow-regulated transcription
factors, such as Kruppel-like factor 2 (KLF2). Indeed, in lympho-
cytes, KLF2 is required for S1P1 expression (Carlson et al., 2006).
We also show that the induction of S1P1 is associated with
cessation of EC sprouting. The effect is EC intrinsic and occurred
prior to the recruitment of mural cells. These findings reveal
a previously unappreciated function of S1P1 to suppress ectopic
sprouting driven by extrinsic VEGF signaling from outside the
vasculature. Even though the precise mechanism by which
S1P1 inhibits ectopic sprouting merits further investigation, our
results suggest crosstalk between S1P1 and VEGFR-2 signaling
pathways during sprouting angiogenesis. Namely, lack of S1P1
results in the local tissue hypoxia and enhanced VEGF-A
production, leading to increased EC proliferation and sprouting.
Further, blockade of VEGFR-2 signaling partially reverses
FTY720-induced vascular hypersprouting. The ability of the
S1P1 receptor to regulate vascular hypersprouting may have
implications in physiology and pathology. For example, exagger-
ated VEGF signaling in pathological conditions, such as tumor
angiogenesis, AMD, and rheumatoid arthritis, could be poten-
tially controlled by activating EC S1P1 signaling.
Second, we found that the ability of S1P1 to regulate sprouting
angiogenesis was independent of Notch signaling. Even though
attenuated Notch signaling by hypomorphic Dll4 gene function
produces a similar phenotype as the S1P1 LOF, analysis of
both in vivo and in vitro systems suggests that S1P1 and Notch
signaling play a role in parallel. Further, recent findings suggest
that Dll4/Notch signaling can be independent of VEGFR-2
signaling during angiogenic sprouting (Benedito et al., 2012).
Given the differential and dynamic expression pattern of Notch
ligands (i.e., Dll4 and Jagged-1) and its relationship to VEGFR-
2 and VEGFR-3 versus a flow-dependent gradient of S1P1
expression during vessel development, it is likely that S1P1
and Notch signaling systems regulate different aspects of the
angiogenic process: Notch/Dll4/Jagged-1 controls tip/stalk cell
transition of the ECs, whereas S1P1 receptor signaling regulates
the stability of the primary vascular network.
Our studies demonstrate that S1P1 function is required for
adherens junction stability in the developing retinal vasculature.
Lack of S1P1 promoted junctional destabilization, as evidenced
by increased tyrosine phosphorylation, trypsin sensitivity of the
extracellular domain of VE-cadherin, and increased permeability
of intravascular dextran from vessels. This occurs concomitantly
with reduced capillary perfusion and enhanced tissue hypoxia.
It is likely that such changes induce local production of VEGF-A,
which was significantly increased in retinal tissue extracts. Since
the S1P1 LOF-induced hypersprouting response is sensitive to
VEGFR-2 inhibition, we suggest that exaggerated VEGF
signaling is critical. Thus, we propose that S1P1 indirectly limits
VEGF signaling in angiogenesis by regulating junction- andDevelopmenflow-dependent mechanisms. However, we cannot exclude the
possibility that S1P1 acts upstream of VEGF and that VEGF
acts as an intermediary of S1P1 effects on flow responses and
junctional stabilization. These possibilities need to be addressed
in relevant in vivo systems.
Surprisingly, S1P1 null retinas did not exhibit any pericyte
recruitment defect in capillaries as well as vascular smooth
muscle cell investment in arteries and veins, in contrast to the
pericyte recruitment defect observed in the dorsal aorta of the
S1pr1/ mouse embryos (Liu et al., 2000). However, breach
of the EC barrier function, reduced flow, and tissue hypoxia
were prominent when S1P1 was ablated in an EC-specific
manner. Although we cannot completely rule out the possibility
that EC S1P1 might control the strength of the interaction
between ECs andmural cells, our findings suggest that the ability
of S1P1 to regulate pericyte recruitment might be tissue-specific
or stage-specific.
Another key finding of this work is that S1P1 is an essential
component of fluid shear stress sensing. In vitro, S1P1 is
required for ECs to sense fluid shear stress and transduce
intracellular signals, such as ERK1/2 and Akt phosphorylation
as well as cell alignment to the direction of flow. Indeed, down-
stream of Akt, critical EC regulators, such as eNOS, are acti-
vated. Furthermore, S1P1R120A mutant, which does not bind
S1P, can still induce shear-mediated responses. Thus, S1P1,
which is induced in the flow-positive vascular networks,
responds not only to blood-derived S1P, but also to biomechan-
ical signals and transduces intracellular events that promote
vascular homeostasis and stability of the nascent vascular
network.
Our data also show that the subcellular localization of S1P1 in
the aortic endothelium in vivo is regulated by flow. In the de-
scending aorta, where the endothelium is constantly subject to
steady laminar shear stress, S1P1 is localized on the plasma
membrane, whereas in the lesser curvature, where the endothe-
lium is exposed to turbulent shear stress, S1P1 appears to be
intracellular. Previous studies have shown that irreversible
internalization of S1P1 is associated with ubiquitination and
degradation (Oo et al., 2007). Therefore, abnormal shear sig-
naling may induce a S1P1 hypomorphic state in ECs. Indeed,
our data demonstrate that S1P1 function in the endothelium
in vivo is necessary to maintain the activity of the eNOS enzyme,
supporting the notion that fluid shear stress signaling in vivo
requires S1P1.
Previous work has attempted to define the molecular details
of the shear stress sensor in EC. Although molecular identity of
the primary sensor has remained elusive, a protein complex
composed of VE-cadherin, VEGFR-2, and PECAM-1 was shown
to be critical for fluid shear stress-induced EC alignment (Tzima
et al., 2005). Further, Tzima et al. showed that this complex was
crucial for fluid shear-mediated phosphorylation of Akt, Src, and
VE-cadherin itself. In addition, other studies have implicated
the critical role of integrins, G proteins, and plasma membrane
domains in shear stress signaling (Hahn and Schwartz, 2009).
The in vivo demonstration that S1P1 regulates phosphorylation
and protease sensitivity of VE-cadherin suggests a critical
mechanism in flow-mediated vascular stabilization. Therefore,
a scenario which merits further investigation is that the shear
sensing complex composition is regulated by S1P1 signaling.tal Cell 23, 600–610, September 11, 2012 ª2012 Elsevier Inc. 607
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domain or can be associated with another molecule capable of
sensing biomechanical forces on the cell surface. In that context,
the association of S1P1 with the lymphocyte activation antigen
CD69 in immune cells and ligand-independent activation of
S1P1 by CD69 has been described (Bankovich et al., 2010;
Shiow et al., 2006). In fact, CD69-induced downregulation of
S1P1 is a key event in lymphocyte retention in secondary
lymphoid organs. Our finding that S1P1 signaling is critical for
ECs to sense biomechanical forces in a S1P-independent
manner suggests the existence of a mechanosensitive corecep-
tor for S1P1 in the vascular endothelium.
Another interesting finding from this study is that a lack of S1P1
perturbed physiological flow in the developing retinal vascular
network. This could be due to decreased activation of eNOS
and reduced production of NO, a potent vasodilator. Further,
disrupted barrier function of the endothelium could also con-
tribute to poor blood flow. Additionally, NO-dependent signaling
pathways have been implicated in the regulation of adherens
junctions in the endothelium (Thibeault et al., 2010).
In summary, this study has revealed several mechanistic
insights in the process of angiogenesis. Plasma-derived S1P
and blood flow transduce signals via S1P1 in ECs to promote
primary vascular network stability and suppress ectopic sprout
formation. We propose that this is a general mechanism by
which blood vessels use both extravascular signals, such as
VEGF, and intravascular signals, including S1P and flow to
achieve a stable primary vascular plexus formation. Accordingly,
we show that the growing vascular network contains S1P1 as
an integral component of the flow-sensing machinery, and
subsequent signaling events are important for vascular stability
and physiological blood flow. This intravascular signaling
paradigm, which appears to be required during development
and homeostasis, may be dysregulated in vascular diseases
associated with inflammatory and neoplastic conditions.
EXPERIMENTAL PROCEDURES
Animals
All animal experiments were approved by the Weill Cornell Institutional Animal
Care and Use Committee. S1pr1LacZ/+ (Liu et al., 2000) and S1pr1f/f (Allende
et al., 2003) mice were provided by Dr. Richard Proia (NIDDK, NIH). S1pr1f/f
mice are crossed to Rosa26-Cre-ERT2 (a gift from Dr. Guo-Hua Fong, Univer-
sity of Connecticut Health Center) (Ghosh et al., 2009) or to VE-Cadherin-Cre-
ERT2 (a gift from Dr. Ralf Adams, Max Planck Institute, Muenster, Germany)
(Pitulescu et al., 2010) to generate S1pr1f/f Rosa26-Cre-ERT2 and S1pr1f/f
VE-Cadherin-Cre-ERT2 mice, respectively. S1p1f/stop/f was generated by
knocking in the transgene into embryonic stem cells (ESCs) and crossed to
Rosa26-Cre-ERT2 to yield S1p1f/stop/f Rosa26-Cre-ERT2 animals.
Littermates from S1pr1f/f ± Rosa26-Cre-ERT2, S1pr1f/f ± VE-Cadherin-Cre-
ERT2, or S1p1f/stop/f ± Rosa26-Cre-ERT2 animals were fed tamoxifen (150 mg
per day) for 3 days from postnatal day 1 (P1) to P3. Genotyping was done
by PCR using tail biopsies or by quantitative real-time PCR using RNA isolated
from retinal tissues. Mouse pups at P4 or P5 were examined for retinal
vascular development, as described previously (Hellstro¨m et al., 2007; Skoura
et al., 2007).
Tissue Whole-Mount Preparation Immunofluorescence
Staining and Imaging
Retinal dissection and immunofluorescence staining was performed as previ-
ously described (Gerhardt et al., 2003; Skoura et al., 2007). Briefly, retinal
tissues were fixed in 4% paraformaldehyde (PFA) in PBS at 4C. Retinas608 Developmental Cell 23, 600–610, September 11, 2012 ª2012 Elswere permeabilized in PBS with 1% BSA, 0.5% Triton X-100 at room temper-
ature (RT) for 30 min, followed by washing in PBlec buffer (PBS (pH 6.8), 1%
Triton X-100, 0.1 mM CaCl2, 0.1 mM MgCl2, and 0.1 mM MnCl2). For aortic
dissection, blood was removed by perfusion with PBS and 4%PFA. The aortic
tree was carefully removed from the heart to the renal aorta and postfixed for
20min in 4%PFA, and greater curvature and descending aortas were isolated.
After quenching using 100 mM glycine (pH 7.4), tissues were permeabilized,
washed, and blocked with PBS containing 2% FCS, 1% BSA, 75 mM NaCl,
18 mM Na3C6H5O7, and 0.05% Triton X-100 for 2 hr at RT (Filipe et al.,
2008). Standard protocols and commercially available antibodies were used
for the whole mount retinal- or en face aortic tissue immunostaining. Confocal
immunofluorescence images of the tissues were captured on an Olympus
Fluoview confocal microscope.
X-Gal Staining
X-gal staining was performed to visualize the expression of S1pr1 in the retina
as previously described (Liu et al., 2000). In brief, the eyes were enucleated
from P4 pups from S1p1LacZ/+ or littermate control, fixed in 4% PFA for
10 min at RT, and postfixed in 2% formaldehyde/2% glutaraldehyde in PBS
for 1 hr on ice. After washing in PBS, retinas were incubated in PBS containing
1 mg/ml of X-gal in 5 mM K3Fe(CN)6 and 2 mM MgCl2 at 37
C until the color
was developed. To define S1pr1-expressing cell types, X-gal-stained retinas
were further processed for PECAM-1 (endothelial cells), GFAP (astrocytes),
or NG2 (pericytes) staining in PBlec buffer (Stenzel et al., 2011).
Assessment of Endothelial Barrier Function by Intracardiac
FITC-Dextran Injection
High-molecular weight FITC-dextran injection was performed to visualize
lumen formation of the retina, as described previously (Gerhardt et al.,
2003), in combination with lectin injection to assess functional vessels/blood
flow. Briefly, FITC-dextran (2000 kDa, Sigma Aldrich, FD2000S) and Alexa-
conjugated lectin (Griffonia simplicifolia GS-IB4 lectin) were prepared in PBS
at the concentration of 25 mg/ml and 1 mg/ml, respectively. P5 S1p1 ECKO
and littermate control were given anesthesia, and intracardiac injection of
FITC-dextran and lectin solution was performed. After 3 min, the eyes were
enucleated, fixed in 4%PFA, and retinal tissue was processed for VE-cadherin
staining and confocal immunofluorescence microscopy.
Retinal Hypoxia Staining
To determine the hypoxic area of the retinal vasculature, P5 pups were
subjected to intraperitoneal injection of the oxygen-sensitive compound
Hypoxyprobe-1 (pimonidazole hydrochloride, Hypoxyprobe, Inc) at a dosage
of 60 mg/kg body weight. After 90 min, the retinas were fixed in 4% PFA,
dissected, permeabilized, and stained with FITC-conjugated anti-Hypoxyp-
robe-1 antibody followed by lectin to visualize vessels (Chen et al., 2009).
Ex Vivo Trypsin Sensitivity Assay
VE-cadherin sensitivity to the trypsin protease in retinal tissue was adapted
as described (Gavard and Gutkind, 2006). Eyeballs from P5 animals were
enucleated, and the retina was exposed by removal of cornea, anterior/
posterior chambers, lens, and hyaloid. The eyecup was incubated with
trypsin/EDTA-containing Hank’s balanced salt solution (HBSS) (0.05%
Trypsin, 20 mM glucose supplement) or HBSS (-Trypsin, 20 mM glucose
supplement). After 1 hr incubation at 37C, the tissue was rinsed three times
in FBS-containing medium to inactivate trypsin and the retina was dissected
out and lysed in radioimmunoprecipitation (RIPA) buffer for western blot
analysis.
Fluid Shear Stress Assay
For short-term shear application (up to 1 hr), human umbilical vein endothelial
cells (HUVEC) were cultured to confluence on fibronectin-coated glass slides
and starved for 3 hr in the medium containing 1% charcoal-stripped FCS,
20 mM hydroxyethyl piperazineethanesulfonic acid (HEPES) (pH 7.4), and
antibiotics, then subjected to fluid shear stress at 8 dyne/cm2 in a parallel
flow chamber as described before (Venkataraman et al., 2008; Wadhwa
et al., 2002). For long-term shear application (12 hr), HUVEC were subjected
to fluid shear stress at 10 dyne/cm2 using BioFlux200 system (Fluxion) accord-
ing to the manufacturer’s instruction in the normal growth mediumevier Inc.
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R120A (Wang et al., 2001) and S5A (Oo et al., 2007) mutants of human S1P1
were overexpressed by lentiviral transduction, and suppression of endoge-
nous S1P1 were achieved either by treating the cells with FTY720-P for 3 hr
or by transducing shRNA (the RNA interference (RNAi) Consortium clone
TRCN0000011362, Sigma-Aldrich) in a lentiviral vector. The alignment of the
cells after 12 hr shear application was evaluated by visualizing VE-cadherin,
actin stress-fibers, eNOS, and nuclei.
Western Blot Analysis
HUVEC or tissues were lysed in RIPA buffer (50 mM Tris (pH 7.4), 150 mM
NaCl, 1 mM EDTA, 0.5% Triton X-100, and 0.5% sodium deoxycholate)
containing phosphatase inhibitors (1 mM Na3VO4, 1 mM NaF, and 5 mM
b-glycerophosphate) and 1 3 protease inhibitors (Calbiochem). Protein
concentration was determined by Bio-Rad assay (Bio-Rad protein dye
reagent, Bio-Rad), and an equal amount of proteins were loaded onto
NUPAGE Novex 4%–12% Bis-Tris gel (Invitrogen). Transferred proteins onto
nitrocellulose membrane were probed with the antibody against total
and phosphorylated ERK, Akt, eNOS, and VE-cadherin or EC markers.
Detailed information for antibodies used is described in the Supplemental
Experimental Procedures.
Quantitative Analysis
Quantification for retinal vascularization and sprouting angiogenesis was
carried out as previously described (Hellstro¨m et al., 2007; Skoura et al.,
2007). Percentage of the vascularized area over total area was analyzed using
Image J software (National Institutes of Health). At least three animals were
used for the analysis of each time point or treatment, unless otherwise indi-
cated. Quantification for shear-mediated EC alignment was performed by
scoring the cells as ‘‘aligned’’ when the longer axis of the cell was more than
2-fold of the shorter axis in length and the longer axis was within ±15 degrees
against the direction of flow. More than 400 cells per treatment in 4 indepen-
dent experiments were analyzed using Image J software.
Statistical analysis was carried out by the unpaired Student’s t test.
The differences were considered statistically significant at p < 0.05. Data
are shown as mean ± SEM, except quantification for the EC alignment
(mean ± SD).
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.doi.
org/10.1016/j.devcel.2012.07.015.
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